AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease-0

Ta are presented in order to accommodate the wide range. The mean between the two groups is significantly different for both AFP and PIVKAII. For the latter, this is predominantly a result of a marked increase in levels in individuals with tumours greater than 5 cm in size.<p><b>Copyright information:</b></p><p>Taken from "AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease"</p><p>http://www.biomedcentral.com/1471-2407/8/200</p><p>BMC Cancer 2008;8():200-200.</p><p>Published online 18 Jul 2008</p><p>PMCID:PMC2488355.</p><p>